Reducing Radiation Damage in Lung Cancer Treatment
Author Information
Author(s): Kataria Tejinder, Rawat Sheh, Sinha SN, Garg C, Bhalla NK, Negi PS
Primary Institution: Rajiv Gandhi Cancer Institute and Research Center, N. Delhi, India
Hypothesis
Can intensity modulated radiotherapy (IMRT) reduce radiation doses to normal tissues while maintaining effective treatment for thoracic malignancies?
Conclusion
IMRT effectively reduced radiation doses to critical normal tissues while achieving desired treatment outcomes.
Supporting Evidence
- IMRT reduced radiation doses by an average of 73% to the heart and 69% to the lungs.
- The 2-year disease-free survival rate was 59%.
- The average number of IMRT fields used was 6.
Takeaway
Doctors used a special kind of radiation treatment to help cancer patients get better while hurting their healthy organs less.
Methodology
12 patients with thoracic malignancies were treated with IMRT, and their treatment plans were analyzed using dose volume histograms.
Limitations
The study had a small sample size and was limited to a specific patient population.
Participant Demographics
Median age was 50 years, with a mix of Hodgkin's and non-Hodgkin's lymphoma, lung cancer, and soft tissue sarcoma patients.
Statistical Information
Confidence Interval
[95% C.I. 13.54, 34.81]
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website